FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Martin Joan

2. Date of Event Requiring Statement (MM/DD/YYYY)
3/7/2017 

3. Issuer Name and Ticker or Trading Symbol

Accelerate Diagnostics, Inc [AXDX]

(Last)        (First)        (Middle)

C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB RD., SUITE 470

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
EXECUTIVE VP AND HEAD OF EMEA /

(Street)

TUCSON, AZ 85714       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   40250   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy)     (1) 3/19/2025   Common Stock   160000   $20.91   D    
Employee Stock Option (right to buy)   2/17/2017   2/17/2026   Common Stock   28549   $11.52   D    

Explanation of Responses:
( 1)  40% of the options vest on March 19, 2017, and the balance vests in 36 equal monthly installments beginning on April 19, 2017.

Remarks:
Exhibit List: Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Martin Joan
C/O ACCELERATE DIAGNOSTICS, INC.
3950 S. COUNTRY CLUB RD., SUITE 470
TUCSON, AZ 85714


EXECUTIVE VP AND HEAD OF EMEA

Signatures
/s/ David Hinnant, attorney-in-fact 3/15/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Accelerate Diagnostics (NASDAQ:AXDX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Accelerate Diagnostics Charts.
Accelerate Diagnostics (NASDAQ:AXDX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Accelerate Diagnostics Charts.